Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But Pharmaceutical Marketers Can Do Much to Address the Problem
Pharma Marketing Network
DECEMBER 21, 2020
While this narrative will undoubtedly evolve throughout the clinical development process, the first draft should be developed as early as the IND-enabling stage. This will create an early shared understanding that will provide a framework for consistent communications throughout clinical development and post launch.
52 
Let's personalize your content